Ribociclib CAS 1256963-02-6, also known as LEE011 and CDK4/6 inhibitor , is an orally available cyclin-dependent kinase (CDK) inhibitor. Ribociclib also specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. We can offer high purity, premium quality, secure, stable and reliable LEE011 to our customers. Manufacture CDK4/6 inhibitor CAS NO 1256963-02-6 from precise formulation raw material using latest technology and advanced equipment. Ribociclib 1256963-02-6 is guarantee 100% genuine high purity powder. Customers can choose at ease.
Thera. Category: CDK4/6 inhibitor
Cas No.: 1256963-02-6
Synonym: LEE011;CDK4/6 inhibitor;CDK4 inhibitor;CDK4-IN-1;Ribociclib;4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine;Ribociclib(LEE011);Ribociclib(Lee011 & CDK 4/6 inhibitor)
Molecular Formula:C22H29ClN8
Molecular Weight:440.97226
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Ribociclib is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.